NEW YORK, May 27, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
North America Prosthetic Heart Valves Market Outlook to 2020
http://www.reportlinker.com/p02133167/North-America-Prosthetic-Heart-Valves-Market-Outlook-to-2020.html
North America Prosthetic Heart Valves Market Outlook to 2020
Summary
GlobalData's new report, "North America Prosthetic Heart Valves Market Outlook to 2020", provides key market data on the North America Prosthetic Heart Valves market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves.
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Prosthetic Heart Valves market wherever available.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Market size for Prosthetic Heart Valves categories - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for the market category.
- Global corporate-level profiles of key companies operating within the North America Prosthetic Heart Valves market.
- Key players covered include Edwards Lifesciences Corporation, Medtronic, Inc., St. Jude Medical, Inc., Sorin Group and CryoLife, Inc.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Prosthetic Heart Valves Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 11
3 Prosthetic Heart Valves Market, North America 12
3.1 Prosthetic Heart Valves Market, North America, Revenue ($m), 2005-2020 12
3.2 Prosthetic Heart Valves Market, North America, Category Comparison by Revenue ($m), 2005-2020 14
3.3 Prosthetic Heart Valves Market, North America, Revenue ($m), 2005-2012 16
3.4 Prosthetic Heart Valves Market, North America, Revenue ($m), 2012-2020 18
3.5 Prosthetic Heart Valves Market, North America, Volume (Units), 2005-2020 20
3.6 Prosthetic Heart Valves Market, North America, Volume (Units), 2005-2012 21
3.7 Prosthetic Heart Valves Market, North America, Volume (Units), 2012-2020 23
3.8 Prosthetic Heart Valves Market, North America, Company Share by Revenue ($m), 2011-2012 25
4 Prosthetic Heart Valves Market, Canada 27
4.1 Prosthetic Heart Valves Market, Canada, Revenue ($m), 2005-2012 27
4.2 Prosthetic Heart Valves Market, Canada, Revenue ($m), 2012-2020 29
4.2.1 Mechanical Heart Valves Market, Canada, Revenue ($m), by Segment, 2005-2012 31
4.2.2 Tissue Heart Valves Market, Canada, Revenue ($m), by Segment, 2005-2012 33
4.2.3 Mechanical Heart Valves Market, Canada, Revenue ($m), by Segment, 2012-2020 35
4.2.4 Tissue Heart Valves Market, Canada, Revenue ($m), by Segment, 2012-2020 37
4.3 Prosthetic Heart Valves Market, Canada, Volume (Units), 2005-2012 39
4.4 Prosthetic Heart Valves Market, Canada, Volume (Units), 2012-2020 41
4.4.1 Mechanical Heart Valves Market, Canada, Volume (Units), by Segment, 2005-2012 43
4.4.2 Tissue Heart Valves Market, Canada, Volume (Units), by Segment, 2005-2012 45
4.4.3 Mechanical Heart Valves Market, Canada, Volume (Units), by Segment, 2012-2020 47
4.4.4 Tissue Heart Valves Market, Canada, Volume (Units), by Segment, 2012-2020 49
4.5 Prosthetic Heart Valves Market, Canada, Average Price ($), 2005-2020 51
4.6 Prosthetic Heart Valves Market, Canada, Distribution Share by Revenue ($m), 2011-2012 53
4.7 Prosthetic Heart Valves Market, Canada, Company Share by Revenue ($m), 2011-2012 54
5 Prosthetic Heart Valves Market, Mexico 56
5.1 Prosthetic Heart Valves Market, Mexico, Revenue ($m), 2005-2012 56
5.2 Prosthetic Heart Valves Market, Mexico, Revenue ($m), 2012-2020 58
5.2.1 Mechanical Heart Valves Market, Mexico, Revenue ($m), by Segment, 2005-2012 60
5.2.2 Tissue Heart Valves Market, Mexico, Revenue ($m), by Segment, 2005-2012 62
5.2.3 Mechanical Heart Valves Market, Mexico, Revenue ($m), by Segment, 2012-2020 64
5.2.4 Tissue Heart Valves Market, Mexico, Revenue ($m), by Segment, 2012-2020 66
5.3 Prosthetic Heart Valves Market, Mexico, Volume (Units), 2005-2012 68
5.4 Prosthetic Heart Valves Market, Mexico, Volume (Units), 2012-2020 70
5.4.1 Mechanical Heart Valves Market, Mexico, Volume (Units), by Segment, 2005-2012 72
5.4.2 Tissue Heart Valves Market, Mexico, Volume (Units), by Segment, 2005-2012 74
5.4.3 Mechanical Heart Valves Market, Mexico, Volume (Units), by Segment, 2012-2020 76
5.4.4 Tissue Heart Valves Market, Mexico, Volume (Units), by Segment, 2012-2020 78
5.5 Prosthetic Heart Valves Market, Mexico, Average Price ($), 2005-2020 80
5.6 Prosthetic Heart Valves Market, Mexico, Distribution Share by Revenue ($m), 2011-2012 82
5.7 Prosthetic Heart Valves Market, Mexico, Company Share by Revenue ($m), 2011-2012 83
6 Prosthetic Heart Valves Market, United States 85
6.1 Prosthetic Heart Valves Market, United States, Revenue ($m), 2005-2012 85
6.2 Prosthetic Heart Valves Market, United States, Revenue ($m), 2012-2020 87
6.2.1 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2005-2012 89
6.2.2 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2005-2012 91
6.2.3 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2012-2020 93
6.2.4 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2012-2020 95
6.3 Prosthetic Heart Valves Market, United States, Volume (Units), 2005-2012 97
6.4 Prosthetic Heart Valves Market, United States, Volume (Units), 2012-2020 99
6.4.1 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2005-2012 101
6.4.2 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2005-2012 103
6.4.3 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2012-2020 105
6.4.4 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2012-2020 107
6.5 Prosthetic Heart Valves Market, United States, Average Price ($), 2005-2020 109
6.6 Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), 2011-2012 111
6.7 Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), 2011-2012 112
7 Overview of Key Companies in North America Prosthetic Heart Valves Market 114
7.1 Edwards Lifesciences Corporation 114
7.1.1 Company Overview 114
7.2 Medtronic, Inc. 114
7.2.1 Company Overview 114
7.3 St. Jude Medical, Inc. 114
7.3.1 Company Overview 114
7.4 Sorin S.p.A. 115
7.4.1 Company Overview 115
8 Prosthetic Heart Valves Market Pipeline Products 116
9 Recent Developments 117
9.1 Corporate Communications 117
9.1.1 Apr 08, 2014: CardiAQ Valve Technologies appoints Paul Cornelison as Vice President of Regulatory Affairs, Quality Assurance & Clinical Affairs 117
9.1.2 Jan 28, 2014: St. Jude Medical Announces Organizational and Executive Leadership Changes 117
9.1.3 Jan 07, 2014: Simbionix Welcomes New Latin and Central American Sales Manager 118
9.1.4 Dec 05, 2013: Anxious Patient Group Calls on NICE to Approve Only Drug Treatment for Ultra-Rare Disease 118
9.1.5 Dec 05, 2013: Edwards Lifesciences Announces Appointment of CFO 120
9.1.6 Nov 04, 2013: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis 121
9.1.7 Aug 13, 2013: Covidien launches Barrx Channel RFA Endoscopic Catheter 121
9.1.8 Aug 02, 2013: China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine 122
9.1.9 Jul 22, 2013: St. Jude Medical Appoints Stefan Widensohler to Its Board of Directors 123
9.1.10 Jul 03, 2013: Novartis Files Patent Infringement Lawsuit Against Intas Pharma Over Generic Myfortic 123
9.1.11 May 14, 2013: Edwards Lifesciences CFO Thomas M Abate To Retire 124
9.2 Financial Announcements 124
9.2.1 Apr 24, 2014: Edwards Lifesciences Reports Strong First Quarter Results 124
9.2.2 Apr 16, 2014: St. Jude Medical Reports First Quarter 2014 Results 126
9.2.3 Feb 18, 2014: Medtronic Reports Third Quarter Earnings 128
9.2.4 Feb 03, 2014: Edwards Lifesciences Reports Strong Fourth Quarter Results 129
9.2.5 Jan 22, 2014: St. Jude Medical Reports Fourth Quarter and Full-Year 2013 Results 131
9.2.6 Dec 09, 2013: St. Jude Medical Announces Fourth Quarter Dividend 133
9.2.7 Nov 26, 2013: FDA approves Varithena (polidocanol injectable foam) for the treatment of patients with varicose veins 133
9.2.8 Nov 19, 2013: Medtronic Reports Second Quarter Earnings 134
9.2.9 Nov 11, 2013: Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2014 136
9.2.10 Oct 28, 2013: Edwards Lifesciences Reports Solid Third Quarter Results 136
9.2.11 Oct 16, 2013: St. Jude Medical Reports Third Quarter 2013 Results 138
9.2.12 Oct 02, 2013: St. Jude Medical Announces Third Quarter 2013 Earnings Conference Call 140
9.2.13 Aug 20, 2013: Medtronic Reports First Quarter Earnings 140
9.2.14 Aug 12, 2013: Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2014 142
9.2.15 Jul 30, 2013: Teleflex subsidiary receives 510(k) clearance for balloon dilatation catheters 142
9.2.16 Jul 30, 2013: St. Jude Medical Announces Third Quarter Dividend 144
9.2.17 Jul 25, 2013: Edwards Lifesciences Reports Solid Second Quarter Results 144
9.2.18 Jul 17, 2013: St. Jude Medical Reports Second Quarter 2013 Results 146
9.2.19 Jul 11, 2013: Edwards Lifesciences to Host Earnings Conference Call on July 25, 2013 147
9.2.20 Jul 02, 2013: St. Jude Medical Announces Second Quarter 2013 Earnings Conference Call 148
9.2.21 May 21, 2013: Medtronic Reports Revenue Of $16.6 Billion In Fiscal 2013 148
9.2.22 May 10, 2013: New Excimer Laser from ZEISS for Refractive Surgery Reduces Treatment Time to the Benefit Both Doctor and Patient 150
9.3 Government and Public Interest 151
9.3.1 Mar 11, 2014: Simbionix Provides Comprehensive Virtual Reality Training for the Fast Arthroscopy Curriculum 151
9.3.2 Jan 06, 2014: Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference 152
9.3.3 Dec 18, 2013: St. Jude Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference 152
9.3.4 Dec 10, 2013: Collaboration Between Simbionix And 1st MSMU To Integrate A Russian Developed Assessment System To Enhance Laparoscopic Training 152
9.3.5 Dec 04, 2013: Medtronic CFO Gary Ellis to Speak at Oppenheimer Healthcare Conference 153
9.3.6 Nov 26, 2013: Medtronic EVP & President Mike Coyle to Speak at Piper Jaffray Healthcare Conference 153
9.3.7 Nov 21, 2013: St. Jude Medical to Present at the Piper Jaffray 25th Annual Healthcare Conference 153
9.3.8 Nov 06, 2013: St. Jude Medical to Present at the 2013 Credit Suisse Healthcare Conference 153
9.3.9 Nov 01, 2013: St. Jude Medical to Present at the 2013 Credit Suisse Healthcare Conference 153
9.3.10 Oct 28, 2013: Edwards Lifesciences to Webcast Analyst Meeting at TCT 25 154
9.3.11 Oct 14, 2013: Edwards Lifesciences to Host Earnings Conference Call on October 28, 2013 154
9.3.12 Sep 06, 2013: Medtronic CFO Gary Ellis to Speak at Morgan Stanley Healthcare Conference 154
9.3.13 Sep 04, 2013: St. Jude Medical to Present at the Stifel Healthcare Conference 154
9.3.14 Sep 03, 2013: St. Jude Medical to Present at the Morgan Stanley Global Healthcare Conference 154
9.3.15 Aug 12, 2013: Edwards Lifesciences to Present at the Canaccord Genuity Growth Conference 154
9.4 Legal And Regulatory 155
9.4.1 Apr 11, 2014: Federal Court Orders Preliminary Injunction on U.S. Sales of Medtronic's Infringing Transcatheter Valve 155
9.4.2 Mar 12, 2014: Venaxis to Discuss Top-Line Results from Pivotal Study of APPY1 Test 155
9.4.3 Jan 22, 2014: Medtronic Statement on U.S. Supreme Court Ruling in Medtronic, Inc. v. Mirowski Family Ventures 156
9.4.4 Nov 14, 2013: Edwards Comments on German Appellate Court Ruling 156
9.4.5 Nov 07, 2013: Law Office of Brodsky & Smith Announces Investigation of Edwards Lifescience 156
9.4.6 Oct 19, 2013: Medtronic Statement on Medical Device Security 157
9.4.7 Oct 18, 2013: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Edwards Lifesciences Corporation 157
9.4.8 Aug 01, 2013: Medtronic Notifies More Than 2,700 Patients Of Lost Records 158
9.4.9 Jul 01, 2013: Bronstein, Gewirtz & Grossman, LLC Announces that a Securities Class Action has been Filed Against Medtronic, Inc. 158
9.5 Other Significant Developments 159
9.5.1 Feb 24, 2014: St. Jude Medical Announces Increase in Quarterly Dividend 159
9.5.2 Feb 13, 2014: Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2014 159
9.5.3 Jan 28, 2014: Medtronic Relocates Its Regional Headquarters to Dubai 159
9.5.4 Dec 09, 2013: Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference 160
9.5.5 Dec 06, 2013: The Edwards Lifesciences Fund to Grant ~$5.6 Million to 450+ Non-Profit Organizations in 2013 162
9.5.6 Dec 04, 2013: Medtronic Issues $500,000 in Health Access Grants to Support Diabetes Services for the Underserved of Greater Los Angeles 162
9.5.7 Aug 22, 2013: Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2014 163
9.6 Product News 163
9.6.1 Mar 31, 2014: Study of transcatheter pulmonary valve shows strong results, reports U-M pediatric interventional cardiologist 163
9.6.2 Dec 27, 2013: Mymetics Enters Into Licensing Agreement With RSV For Respiratory Syncytial Virus Vaccine 165
9.6.3 Nov 18, 2013: Simbionix New ANGIO Mentor Suite Promotes Endovascular Team Training in a True-to-Life Clinical Environment 167
9.6.4 Nov 15, 2013: FDA Classifies Medtronic's Worldwide Voluntary Field Action on Guidewires as Class I Recall 168
9.6.5 Nov 14, 2013: Endovascular Aneurysm Training Module Now Supports Vascutek's Anaconda Devices 168
9.7 Strategy And Business Planning 169
9.7.1 Nov 13, 2013: Edwards Lifesciences Expands Singapore Manufacturing Facility 169
9.7.2 Sep 17, 2013: Medtronic Opens New Customer Innovation Centre in Galway, Ireland 170
9.7.3 Sep 02, 2013: Medtronic announces formation of hospital solutions business aimed at driving efficiencies 170
9.7.4 Aug 29, 2013: Medtronic To Set Up Global Center Of Excellence In Singapore For Business Model Innovation 172
10 Appendix 173
10.1 Research Methodology 174
10.1.1 Coverage 174
10.1.2 Secondary Research 174
10.1.3 Primary Research 175
10.1.4 Market Modeling and Forecasting 176
10.1.5 Company Share Analysis 179
10.1.6 Distribution Share Analysis 180
10.2 Expert Panel 180
10.3 GlobalData Consulting 181
10.4 Contact Us 181
10.5 Disclaimer 181
1.1 List of Tables
Table 1: Prosthetic Heart Valves Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020 13
Table 2: Prosthetic Heart Valves Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020 15
Table 3: Prosthetic Heart Valves Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012 17
Table 4: Prosthetic Heart Valves Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020 19
Table 5: Prosthetic Heart Valves Market, North America, Volume (Units), 2005-2020 20
Table 6: Prosthetic Heart Valves Market, North America, Volume (Units), Historic, 2005-2012 22
Table 7: Prosthetic Heart Valves Market, North America, Volume (Units), Forecast, 2012-2020 24
Table 8: Prosthetic Heart Valves Market, North America, Company Share by Revenue ($m), USD Constant, 2011-2012 26
Table 9: Prosthetic Heart Valves Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 28
Table 10: Prosthetic Heart Valves Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 30
Table 11: Mechanical Heart Valves Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 32
Table 12: Tissue Heart Valves Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 34
Table 13: Mechanical Heart Valves Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 36
Table 14: Tissue Heart Valves Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 38
Table 15: Prosthetic Heart Valves Market, Canada, Volume (Units), Historic, 2005-2012 40
Table 16: Prosthetic Heart Valves Market, Canada, Volume (Units), Forecast, 2012-2020 42
Table 17: Mechanical Heart Valves Market, Canada, Volume (Units), Historic, 2005-2012 44
Table 18: Tissue Heart Valves Market, Canada, Volume (Units), Historic, 2005-2012 46
Table 19: Mechanical Heart Valves Market, Canada, Volume (Units), Forecast, 2012-2020 48
Table 20: Tissue Heart Valves Market, Canada, Volume (Units), Forecast, 2012-2020 50
Table 21: Prosthetic Heart Valves Market, Canada, Average Price ($), Historic, 2005-2012 51
Table 22: Prosthetic Heart Valves Market, Canada, Average Price ($), Forecast, 2012-2020 52
Table 23: Prosthetic Heart Valves Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 53
Table 24: Prosthetic Heart Valves Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 55
Table 25: Prosthetic Heart Valves Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 57
Table 26: Prosthetic Heart Valves Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 59
Table 27: Mechanical Heart Valves Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 61
Table 28: Tissue Heart Valves Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 63
Table 29: Mechanical Heart Valves Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 65
Table 30: Tissue Heart Valves Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 67
Table 31: Prosthetic Heart Valves Market, Mexico, Volume (Units), Historic, 2005-2012 69
Table 32: Prosthetic Heart Valves Market, Mexico, Volume (Units), Forecast, 2012-2020 71
Table 33: Mechanical Heart Valves Market, Mexico, Volume (Units), Historic, 2005-2012 73
Table 34: Tissue Heart Valves Market, Mexico, Volume (Units), Historic, 2005-2012 75
Table 35: Mechanical Heart Valves Market, Mexico, Volume (Units), Forecast, 2012-2020 77
Table 36: Tissue Heart Valves Market, Mexico, Volume (Units), Forecast, 2012-2020 79
Table 37: Prosthetic Heart Valves Market, Mexico, Average Price ($), Historic, 2005-2012 80
Table 38: Prosthetic Heart Valves Market, Mexico, Average Price ($), Forecast, 2012-2020 81
Table 39: Prosthetic Heart Valves Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2011-2012 82
Table 40: Prosthetic Heart Valves Market, Mexico, Company Share by Revenue ($m), USD Constant, 2011-2012 84
Table 41: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 86
Table 42: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 88
Table 43: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 90
Table 44: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 92
Table 45: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 94
Table 46: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 96
Table 47: Prosthetic Heart Valves Market, United States, Volume (Units), Historic, 2005-2012 98
Table 48: Prosthetic Heart Valves Market, United States, Volume (Units), Forecast, 2012-2020 100
Table 49: Mechanical Heart Valves Market, United States, Volume (Units), Historic, 2005-2012 102
Table 50: Tissue Heart Valves Market, United States, Volume (Units), Historic, 2005-2012 104
Table 51: Mechanical Heart Valves Market, United States, Volume (Units), Forecast, 2012-2020 106
Table 52: Tissue Heart Valves Market, United States, Volume (Units), Forecast, 2012-2020 108
Table 53: Prosthetic Heart Valves Market, United States, Average Price ($), Historic, 2005-2012 109
Table 54: Prosthetic Heart Valves Market, United States, Average Price ($), Forecast, 2012-2020 110
Table 55: Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 111
Table 56: Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 113
Table 57: Prosthetic Heart Valves Market Pipeline Products 116
Table 58 Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 176
1.2 List of Figures
Figure 1: Prosthetic Heart Valves Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020 12
Figure 2: Prosthetic Heart Valves Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020 14
Figure 3: Prosthetic Heart Valves Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012 16
Figure 4: Prosthetic Heart Valves Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020 18
Figure 5: Prosthetic Heart Valves Market, North America, Volume (Units), 2005-2020 20
Figure 6: Prosthetic Heart Valves Market, North America, Volume (Units), Historic, 2005-2012 21
Figure 7: Prosthetic Heart Valves Market, North America, Volume (Units), Forecast, 2012-2020 23
Figure 8: Prosthetic Heart Valves Market, North America, Company Share (%), 2012 25
Figure 9: Prosthetic Heart Valves Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 27
Figure 10: Prosthetic Heart Valves Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 29
Figure 11: Mechanical Heart Valves Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 31
Figure 12: Tissue Heart Valves Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 33
Figure 13: Mechanical Heart Valves Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 35
Figure 14: Tissue Heart Valves Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 37
Figure 15: Prosthetic Heart Valves Market, Canada, Volume (Units), Historic, 2005-2012 39
Figure 16: Prosthetic Heart Valves Market, Canada, Volume (Units), Forecast, 2012-2020 41
Figure 17: Mechanical Heart Valves Market, Canada, Volume (Units), Historic, 2005-2012 43
Figure 18: Tissue Heart Valves Market, Canada, Volume (Units), Historic, 2005-2012 45
Figure 19: Mechanical Heart Valves Market, Canada, Volume (Units), Forecast, 2012-2020 47
Figure 20: Tissue Heart Valves Market, Canada, Volume (Units), Forecast, 2012-2020 49
Figure 21: Prosthetic Heart Valves Market, Canada, Company Share (%), 2012 54
Figure 22: Prosthetic Heart Valves Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 56
Figure 23: Prosthetic Heart Valves Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 58
Figure 24: Mechanical Heart Valves Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 60
Figure 25: Tissue Heart Valves Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 62
Figure 26: Mechanical Heart Valves Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 64
Figure 27: Tissue Heart Valves Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 66
Figure 28: Prosthetic Heart Valves Market, Mexico, Volume (Units), Historic, 2005-2012 68
Figure 29: Prosthetic Heart Valves Market, Mexico, Volume (Units), Forecast, 2012-2020 70
Figure 30: Mechanical Heart Valves Market, Mexico, Volume (Units), Historic, 2005-2012 72
Figure 31: Tissue Heart Valves Market, Mexico, Volume (Units), Historic, 2005-2012 74
Figure 32: Mechanical Heart Valves Market, Mexico, Volume (Units), Forecast, 2012-2020 76
Figure 33: Tissue Heart Valves Market, Mexico, Volume (Units), Forecast, 2012-2020 78
Figure 34: Prosthetic Heart Valves Market, Mexico, Company Share (%), 2012 83
Figure 35: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 85
Figure 36: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 87
Figure 37: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 89
Figure 38: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 91
Figure 39: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 93
Figure 40: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 95
Figure 41: Prosthetic Heart Valves Market, United States, Volume (Units), Historic, 2005-2012 97
Figure 42: Prosthetic Heart Valves Market, United States, Volume (Units), Forecast, 2012-2020 99
Figure 43: Mechanical Heart Valves Market, United States, Volume (Units), Historic, 2005-2012 101
Figure 44: Tissue Heart Valves Market, United States, Volume (Units), Historic, 2005-2012 103
Figure 45: Mechanical Heart Valves Market, United States, Volume (Units), Forecast, 2012-2020 105
Figure 46: Tissue Heart Valves Market, United States, Volume (Units), Forecast, 2012-2020 107
Figure 47: Prosthetic Heart Valves Market, United States, Company Share (%), 2012 112
Figure 48: GlobalData Epidemiology-Based Forecasting Model 178
Figure 49: GlobalData Capital Equipment-Based Forecasting Model 179
Figure 50: Primary Interviews by Participant Type (%) 180
Companies Mentioned
Edwards Lifesciences Corporation
Medtronic, Inc.
St. Jude Medical, Inc.
Sorin S.p.A.
To order this report: North America Prosthetic Heart Valves Market Outlook to 2020
http://www.reportlinker.com/p02133167/North-America-Prosthetic-Heart-Valves-Market-Outlook-to-2020.html
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article